All Things Considered on NPR News

In the 1980s, Elliott Sharp was the height of New York City cool, a central part of that town's experimental music scene. His creations were inspired by advanced mathematical concepts. He tuned his guitars according to the Fibonacci Sequence and wrote challenging pieces inspired by fractal geometry.

President Obama named a new national monument on Friday: Chimney Rock in southwestern Colorado. With two sandstone spires soaring from a mesa, not only is Chimney Rock a spectacular place; it also provides a fascinating glimpse into the ancient people who lived in that region more than 1,000 years ago.

And then there were three — record labels, that is. Regulators in the United States and Europe have approved the acquisition of EMI Music by Univeral Music Group. The combined label will own close to 40 percent of the world music market with a trove of acts that includes The Beatles.

The Obama administration has named Chimney Rock, in Colorado as a new national monument. The ancient people who lived there were a little bit like modern Americans — they had an elite class and a 99 percent just like us.

Transcript

AUDIE CORNISH, HOST:

Finally this hour, to California, where space shuttle Endeavour made its final flight today. Endeavour left Andrews Air Force Base this morning on the back of a 747. It flew over San Francisco and Sacramento before heading south to Los Angeles. There, it will find new life as an exhibit in a science museum. Before Endeavour touched down, it made a low-level pass over a number of Southern California landmarks. NPR's Mandalit del Barco was with some elementary school students as the shuttle flew by.

Robert Siegel talks to regular political commentators, E.J. Dionne of The Washington Post and Brookings Institution, and David Brooks of The New York Times. They discuss Mitt Romney's "47 percent," new polls on the presidential race, and close Senate races.

Jerome Horwitz, the developer of the antiretroviral drug AZT, died earlier this month. Audie Cornish speaks with Paul Volberding, Director of the Center for AIDS Research at the University of San Francisco about how AZT revolutionized AIDS research.